Stocksigma LogoStocksigma Logo

Onyx Biotec Reports Zero Deviation in IPO Proceeds Utilization for H1 FY27

Onyx Biotec confirmed no deviation in utilizing proceeds from its 22nd Nov'24 IPO for the half-year ended 30th Sep'26

Onyx Biotec Reports Zero Deviation in IPO Proceeds Utilization for H1 FY27

Onyx Biotec Ltd 路 Others (Uncategorized) 路 14 Nov 2026, 10:44 pm

Onyx Biotec Reports Zero Deviation in IPO Proceeds Utilization for H1 FY27 Onyx Biotec confirmed no deviation in utilizing proceeds from its 22nd Nov'24 IPO for the half-year ended 30th Sep'26. Net issue proceeds increased to INR 2,538.02 lakhs from INR 2,531.75 lakhs due to lower actual issue expenses of INR 396.08 lakhs versus INR 402.35 lakhs estimated, raising the general corporate allocation to INR 606.27 lakhs. Cumulative fund deployment reached INR 2,464.27 lakhs, including INR 1,200.00 lakhs for loan repayments. Unutilized funds comprise INR 67.00 lakhs in fixed deposits and INR 6.85 lakhs in an HDFC Bank IPO account.

Original exchange filing (PDF)

More announcements from Onyx Biotec Ltd

All Onyx Biotec Ltd announcements